Indication
Inflammatory Mediators
1 clinical trial
1 product
Clinical trial
An Innovative Proof-of-concept Approach to Identify Age-modulating Drugs Capable of Reversing Inflammation and Re-setting the Epigenetic Clock (Topical-RAPA)Status: Completed, Estimated PCD: 2022-04-15
Product
Rapamycin